Filing Details
- Accession Number:
- 0001493152-22-015773
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-06-03 06:08:33
- Reporting Period:
- 2022-05-31
- Accepted Time:
- 2022-06-03 06:08:33
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1716166 | Vivos Therapeutics Inc. | VVOS | Surgical & Medical Instruments & Apparatus (3841) | 813224056 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1835498 | Kirk Ronald Huntsman | 9137 S. Ridgeline Blvd, Suite 135 Highlands Ranch CO 80129 | Chief Executive Officer | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-05-31 | 8,000 | $2.03 | 23,500 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-06-01 | 4,000 | $1.83 | 27,500 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,740,000 | Indirect | See footnote |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in four separate transactions ranging from $2.02 to $2.035 on May 31, 2022. The reporting person undertakes to provide to Vivos Therapeutics, Inc., any security holder of Vivos Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.
- Shares held by Coronado V Partners, LLC, of which the reporting person is a member and manager.